FDA Drug recall D-0340-2026
Cetrorelix Acetate for Injection (Kit), 0.25 mg per vial, Single-Dose Kit, Rx Only, Mfd. for: Meitheal Pharmaceuticals, Chicago, IL NDC 712…
- FDA Drug
- Class II
- ongoing
- Published 2026-02-18
On 2026-02-18 the FDA classified a Class II recall of Cetrorelix Acetate for Injection (Kit), 0.25 mg per vial, Single-Dose Kit, Rx Only, Mfd. for: Meitheal Pharmaceuticals, Chicago, IL NDC 712… by Meitheal Pharmaceuticals, citing defective Delivery System: Missing or duplicated needles within the injection kit.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0340-2026 |
| Classification | Class II |
| Status | ongoing |
| Initiated | 2026-02-09 |
| Published | 2026-02-18 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Meitheal Pharmaceuticals |
| Distribution | US |
Product
Cetrorelix Acetate for Injection (Kit), 0.25 mg per vial, Single-Dose Kit, Rx Only, Mfd. for: Meitheal Pharmaceuticals, Chicago, IL NDC 71288-558-90.
Reason
Defective Delivery System: Missing or duplicated needles within the injection kit
Identifiers
| ndc | 71288-558-90 |
|---|---|
| ndc | 71288-556-02 |
| ndc | 71288-557-81 |
| code_info | Lot Q4E0112A, Exp.: 30 Apr 2027 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: ongoing.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0340-2026%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.